Medicare Enrolled
Dr. Arelis Madera, MD
Endocrinology · Port Charlotte, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Madera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Madera?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Madera
Dr. Arelis Madera is an endocrinology specialist in Port Charlotte, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Madera performed 5,191 Medicare services across 3,236 unique beneficiaries.
Between the years covered by Open Payments, Dr. Madera received a total of $1,784,759 from 69 pharmaceutical and/or device companies across 3452 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Madera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 12% volume in FL
$1,784,759 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 74893 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗5,191
Medicare services
Top 12% in FL for endocrinology
3,236
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~273 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,566 | $92 | $264 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
1,309 | $26 | $71 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
284 | $8 | $17 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
219 | $3 | $7 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
177 | $10 | $21 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
153 | $10 | $19 |
| New patient office visit, complex (60-74 min) | 128 | $160 | $459 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
125 | $16 | $34 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
120 | $6 | $12 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
120 | $5 | $10 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
117 | $13 | $27 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
117 | $9 | $18 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
113 | $128 | $371 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $122 | $347 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
90 | $7 | $17 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
81 | $45 | $125 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
80 | $107 | $296 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $65 | $187 |
| Total cortisol level test A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands. |
41 | $16 | $33 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
35 | $15 | $30 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
27 | $29 | $59 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $82 | $235 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
18 | $49 | $132 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
18 | $1 | $1 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
17 | $10 | $26 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $41 | $117 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
12 | $8 | $17 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
11 | $97 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
1.9% medium
97.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,784,759
Total received (2018-2024)
Avg $254,966/year across 7 years
Top 0% in FL for endocrinology
69
Companies
3,452
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,755,943 (98.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,963 (1.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,854 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$228,447
2023
$209,756
2022
$281,589
2021
$240,865
2020
$171,840
2019
$316,418
2018
$335,843
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$634,691
Novo Nordisk Inc
$422,109
Bayer HealthCare Pharmaceuticals Inc.
$105,358
SANOFI-AVENTIS U.S. LLC
$99,149
Dexcom, Inc.
$92,046
Bayer Healthcare Pharmaceuticals Inc.
$88,692
AstraZeneca Pharmaceuticals LP
$70,000
Abbott Laboratories
$62,407
Radius Health, Inc.
$42,854
DEXCOM, INC.
$34,833
Xeris Pharmaceuticals, Inc.
$27,975
Amgen Inc.
$24,163
Janssen Pharmaceuticals, Inc
$19,451
AbbVie, Inc.
$14,659
Merck Sharp & Dohme Corporation
$13,074
AbbVie Inc.
$11,011
Senseonics, Incorporated
$6,128
MannKind Corporation
$3,229
Ascensia Diabetes Care Us Inc.
$2,692
Insulet Corporation
$1,552
Zealand Pharma US, Inc.
$1,085
Tandem Diabetes Care, Inc.
$715
Medtronic MiniMed, Inc.
$609
Mannkind Corporation
$511
Corcept Therapeutics
$480
Shire North American Group Inc
$407
Novartis Pharmaceuticals Corporation
$373
Astellas Pharma US Inc
$328
Horizon Therapeutics plc
$281
Valeritas, Inc.
$266
Medtronic, Inc.
$266
Amarin Pharma Inc.
$227
Companion Medical, Inc.
$219
RECORDATI_RARE_DISEASES_INC.
$192
ABBVIE INC.
$191
Vanda Pharmaceuticals Inc.
$178
Almatica Pharma LLC
$141
IBSA Pharma Inc.
$135
Takeda Pharmaceuticals U.S.A., Inc.
$125
Paratek Pharmaceuticals, Inc.
$125
LIFESCAN, INC.
$123
BETA BIONICS, INC.
$121
Regeneron Healthcare Solutions, Inc.
$121
Kyowa Kirin, Inc.
$117
Averitas Pharma Inc.
$112
Nevro Corp.
$112
CeQur Corporation
$111
Ipsen Biopharmaceuticals, Inc
$96
Amneal Pharmaceuticals LLC
$93
LifeScan, Inc.
$89
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$89
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
Allergan Inc.
$74
Currax Pharmaceuticals LLC
$55
GRT US Holding, Inc.
$55
Nestle HealthCare Nutrition Inc.
$53
Ultragenyx Pharmaceutical Inc.
$46
PFIZER INC.
$35
Rhythm Pharmaceuticals, Inc.
$33
Kowa Pharmaceuticals America, Inc.
$30
Madrigal Pharmaceuticals
$27
AIMMUNE THERAPEUTICS, INC.
$26
Neurocrine Biosciences, Inc.
$24
Esperion Therapeutics, Inc.
$22
Lexicon Pharmaceuticals, Inc.
$21
Gemini Laboratories, LLC
$19
Ferring Pharmaceuticals Inc.
$18
NESTLE HEALTHCARE NUTRITION INC.
$14
Ascensia Diabetes Care US Inc.
$12
Top 3 companies account for 65.1% of total payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BYDUREON · BYSTOLIC · CONTRAVE · CREON · CRYSVITA · CYCLOSET · CeQur Simplicity · Corlanor · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · EVKEEZA · Eversense · FANAPT · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GATTEX · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LEQVIO · LINZESS · LYUMJEV · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 530G · Minimed 630G · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NUZYRA · Non-Covered · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QUTENZA · Qutenza · RECORLEV · RESMETIROM · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · SYNTHROID · Saxenda · Senza · Somatuline Depot · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VIBERZI · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIGDUO · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · ZEPBOUND · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for endocrinology in FL.
Equivalent to $34,382 per 100 Medicare services performed
Geographic Context
Endocrinologists within 10 mi
12
Per 100K population
6.2
County median income
$66,154
Nearest hospital
Adventhealth Port Charlotte
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Madera is a clinical cardiology specialist, with above-average Medicare volume (top 12% in FL), with speaking/promotional industry engagement in the top 0% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Madera experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Madera performed 1,566 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Madera receive payments from pharmaceutical companies?
Yes. Dr. Madera received a total of $1,784,759 from 69 companies across 3,452 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Madera's costs compare to other endocrinologists in Port Charlotte?
Dr. Madera's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Madera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Port Charlotte
Browse endocrinologists in Port Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in FL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in FL
Which FL endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology